Login   |  Users Online: 348 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
RESEARCH ARTICLE
Year : 2008  |  Volume : 29  |  Issue : 4  |  Page : 201-206

Clinical Evaluation of 'Menorid Capsules' in the Management of Menopausal Syndrome


1 Professor & Head, P.G. Dept. of Kayachikitsa, National Institute of Ayurveda and S.M.S. Medical College & Hospital, Jaipur - 302002 (Rajasthan), India
2 Associate Professor, Dept. of Obs. & Gynae., S.M.S. Medical college & Hospital, S.M.S. Medical College & Hospital, Jaipur - 302002 (Rajasthan), India
3 M.D. (Ay.) Scholar, P.G. Dept. of Kayachikitsa, National Institute of Ayurveda and S.M.S. Medical College & Hospital, Jaipur - 302002 (Rajasthan), India

Correspondence Address:
A K Sharma
Professor & Head, P.G. Dept. of Kayachikitsa, National Institute of Ayurveda and S.M.S. Medical College & Hospital, Jaipur - 302002 (Rajasthan)
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

The study was conducted for the clinical evaluation of 'Menorid Capsules' (A Proposed Herbomineral formulation) in the management of Menopausal Syndrome on various scientific parameters. Thirty clinically diagnosed cases were selected from O.P.D. / I.P.D. of the National Institute of Ayurveda Hospital, Jaipur and S.M.S. Medical College attached Hospital, Mahila Chikitsalaya, Jaipur. The cases were randomly divided into three groups - Group I (Control Group - Oral Conjugated equine estrogen), Group II (Trial group - Menorid Capsules) and Group III (Placebo group - Capsules filled with Starch). It was observed that overall clinical improvement was maximum in patients of Group II. Overall improvement in Laboratory parameters was maximum in patients of Group I. Patients of Group III developed mild improvement in the feeling of wellbeing. The patients of Group I developed some adverse symptoms, but no adverse effects were reported in any of the patients of the Group II & III. From the current research project, it can be concluded that the trial drug 'Menorid capsules' is a safe, dependable and cost effective remedy for the management of the patients of Menopausal Syndrome.


[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed812    
    Printed69    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal